Boston University School of Public Health (BUSPH) researchers will share in a seven-year, $21 million grant awarded to Boston Medical Center (BMC) to investigate why the bacteria that cause tuberculosis (TB) affect individuals in different ways.
The grant to BMC from the National Institutes of Health will allow researchers from the BU schools of public health and medicine to examine the biological factors, or biomarkers, that indicate whether a person infected with Mycobacterium tuberculosis (MTB) is likely to develop symptoms of the disease in his or her lifetime or will be cured by treatment. The ultimate goal of the research is to develop new tools for more effective prevention and treatment of TB.
“There have been strides in reducing TB mortality rates worldwide, but it remains one of the most deadly diseases and disproportionately affects women and individuals in low and middle-income countries,” said Dr. Jerrold Ellner, chief of infectious diseases at BMC and professor of medicine at BU School of Medicine, who will serve as the study’s principal investigator.
BU collaborators on the study include Dr. C. Robert Horsburgh, professor of epidemiology at BUSPH; Dr. Laura White, associate professor of biostatistics at BUSPH; and Dr. Edwards Jones-Lopez, infectious disease physician at BMC, assistant professor of medicine at BUSM and assistant professor of epidemiology at BUSPH.
To read more about the study, go to: http://www.bu.edu/sph/2014/11/13/sph-researchers-join-in-major-tb-study/